| Requip linked to Compulsive Behavior The side effects of drugs like Requip (dopamine agonists) have caused bankruptcies, broken marriages, depression and even suicide. As a result, more than 300 lawsuits against the makers of these medications have been filed in courts around the country. |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| Call for a FREE case evaluation: (713) 255-2055 |
| Requip Litigation |
dopamine agonist, Mirapex, eight developed gambling addictions. For most
In July 2005, Mayo Clinic researchers reported more documented behavior that
supported an association between Requip and other dopamine agonists with
gambling addiction and compulsive behaviors. The report detailed 11 Parkinson's
patients who developed gambling problems while taking Requip or similar drugs
between 2002 and 2004. After the study’s completion, the Mayo clinic researchers
identified 14 additional patients with the problem. Finally, results from the largest
study ever to investigate the connection between compulsive behavior and dopamine
agonists like Requip was presented at the International Congress of Parkinson’s
Disease and Movement Disorders conference in Chicago in 2008. The study found
that, out of 3,000 patients from 46 medical centers in the United States and
Canada, 13 percent of those taking dopamine agonists suffered at least one of four
serious behavioral addictions.
The 2008 dopamine agonists study sent a strong warning to the medical
community. In an article in The Chicago Tribune, some doctors said that they
would no longer prescribe drugs like Requip. Others said they were strongly
warning their patients who used Requip and similar drugs to be on the lookout for
signs that they might be developing compulsive behaviors.
In July 2005, Mayo Clinic researchers reported more documented behavior that
supported an association between Requip and other dopamine agonists with
gambling addiction and compulsive behaviors. The report detailed 11 Parkinson's
patients who developed gambling problems while taking Requip or similar drugs
between 2002 and 2004. After the study’s completion, the Mayo clinic researchers
identified 14 additional patients with the problem. Finally, results from the largest
study ever to investigate the connection between compulsive behavior and dopamine
agonists like Requip was presented at the International Congress of Parkinson’s
Disease and Movement Disorders conference in Chicago in 2008. The study found
that, out of 3,000 patients from 46 medical centers in the United States and
Canada, 13 percent of those taking dopamine agonists suffered at least one of four
serious behavioral addictions.
The 2008 dopamine agonists study sent a strong warning to the medical
community. In an article in The Chicago Tribune, some doctors said that they
would no longer prescribe drugs like Requip. Others said they were strongly
warning their patients who used Requip and similar drugs to be on the lookout for
signs that they might be developing compulsive behaviors.
| "When companies place profits over the welfare of people we, as lawyers, should feel a special need to hold them accountable. accountability, positive change." Todd Kelly |
